Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Morgan Stanley Reiterates EqualWeight Rating for Best Buy Co with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Financing and finances
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

On March 2, 2024, analyst Simeon Gutman of Morgan Stanley reiterated an Equal-Weight rating for Best Buy Co (NYSE: BBY) while increasing the price target from $80 to $82. This adjustment showcases optimism regarding the company’s financial performance, highlighting efficient cost management and a consistent rating in the face of market volatility. The decision by Morgan Stanley demonstrates a belief in Best Buy’s ability to continue growing and maintain stability in the future.

Best Buy Stock Price Drops on March 2, 2024: What Investors Need to Know

On March 2, 2024, Best Buy Co., Inc. (BBY) experienced a significant drop in its stock price. The stock closed at $77.92, which was a decrease of $2.96 or 3.66% from the previous market close. However, there was a slight uptick in after-hours trading, with the stock rising $0.09.

Despite the drop in price on this particular day, BBY is still trading in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been relatively stable over the long term, even with the recent price decrease.

Investors may be wondering what caused this drop in BBY’s stock price. It’s important to note that stock prices can be influenced by a variety of factors, including market conditions, company performance, and industry trends. Without more information, it’s difficult to pinpoint the exact reason for the decline in BBY’s stock price on March 2.

For investors considering buying or selling BBY stock, it’s important to conduct thorough research and analysis to make informed decisions. Looking at the overall performance of the company, its financial health, and industry trends can provide valuable insights into the potential future performance of the stock.

As always, it’s important for investors to carefully consider their investment goals, risk tolerance, and time horizon before making any decisions in the stock market. While short-term fluctuations in stock prices can be concerning, it’s essential to focus on the long-term prospects of the company and its ability to generate returns for shareholders over time.

Best Buy Co., Inc. (BBY) Stock Analysis: Revenue and EPS Surge in Latest Financial Data

Best Buy Co., Inc. (BBY) is a well-known consumer electronics retailer. On March 2, 2024, BBY stock showed interesting trends based on the latest financial data provided by CNN Money.

Total revenue for Best Buy Co., Inc. was $43.45 billion over the past year, with a significant increase to $14.65 billion in the fourth quarter. Net income also saw a similar pattern, with $1.24 billion in annual net income and $460.00 million in the fourth quarter.

Earnings per share (EPS) for Best Buy Co., Inc. were $5.68 over the past year, dropping by 9.66% compared to the previous year. However, EPS surged to $2.12 in the fourth quarter, marking an impressive 75.96% increase since the last quarter.

Overall, BBY stock performances on March 2, 2024, reflect a mix of challenges and opportunities for Best Buy Co., Inc. Investors will continue to monitor the company’s financial performance and strategic decisions to assess its long-term prospects in the competitive consumer electronics market.

Tags: BBY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Investings on laptops and finances

Wells Fargo Analyst Upgrades Price Target for Chart Industries NYSE GTLS

Biotechnology Stock Market Today (1)

Annexon Inc Receives Upgrade from JP Morgan and Positive Outlook for GBS Treatment

Finance_Banking (2)

Analyst Chris Parkinson from Wolfe Research Rates Element Solutions as Peer Perform

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com